Alyssa Ziman

2.3k total citations
69 papers, 1.2k citations indexed

About

Alyssa Ziman is a scholar working on Biochemistry, Management of Technology and Innovation and Hematology. According to data from OpenAlex, Alyssa Ziman has authored 69 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Biochemistry, 22 papers in Management of Technology and Innovation and 22 papers in Hematology. Recurrent topics in Alyssa Ziman's work include Blood transfusion and management (34 papers), Blood donation and transfusion practices (22 papers) and Blood groups and transfusion (20 papers). Alyssa Ziman is often cited by papers focused on Blood transfusion and management (34 papers), Blood donation and transfusion practices (22 papers) and Blood groups and transfusion (20 papers). Alyssa Ziman collaborates with scholars based in United States, Canada and Brazil. Alyssa Ziman's co-authors include Dennis Goldfinger, Meghan Delaney, Mark H. Yazer, Nancy M. Dunbar, Claudia S. Cohn, Silvano Wendel, Joan Cid, Torunn Oveland Apelseth, Simon Stanworth and Shan Yuan and has published in prestigious journals such as The Lancet, Blood and Neurology.

In The Last Decade

Alyssa Ziman

64 papers receiving 1.2k citations

Peers

Alyssa Ziman
Edwin Massey United Kingdom
José Orlando Bordin Brazil
G. Andreu France
Markus B. Funk Germany
Ellen Klapper United States
S. J. Urbaniak United Kingdom
Stella Larsson Sweden
J. W. Andersen United States
Michael Müller‐Steinhardt Germany
Byron A. Myhre United States
Edwin Massey United Kingdom
Alyssa Ziman
Citations per year, relative to Alyssa Ziman Alyssa Ziman (= 1×) peers Edwin Massey

Countries citing papers authored by Alyssa Ziman

Since Specialization
Citations

This map shows the geographic impact of Alyssa Ziman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alyssa Ziman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alyssa Ziman more than expected).

Fields of papers citing papers by Alyssa Ziman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alyssa Ziman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alyssa Ziman. The network helps show where Alyssa Ziman may publish in the future.

Co-authorship network of co-authors of Alyssa Ziman

This figure shows the co-authorship network connecting the top 25 collaborators of Alyssa Ziman. A scholar is included among the top collaborators of Alyssa Ziman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alyssa Ziman. Alyssa Ziman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bloch, Evan M., Jeremy W. Jacobs, Bruce S. Sachais, et al.. (2025). Revisiting whole blood transfusion for the massively bleeding patient: The origins of resistance to change. Transfusion.
2.
3.
Yazer, Mark H., Nancy M. Dunbar, John R. Hess, et al.. (2023). Transfusion of ABO‐group identical red blood cells following uncrossmatched transfusion does not lead to higher mortality in civilian trauma patients. Transfusion. 63(S3). S46–S53. 1 indexed citations
4.
Lee, Christine, et al.. (2022). Logistics of managing a trauma whole blood inventory in a civilian level 1 trauma center. Transfusion. 62(9). 1772–1778. 2 indexed citations
5.
Buren, Nancy L. Van, Srijana Rajbhandary, Jed B. Gorlin, et al.. (2022). Demographics of first‐time donors returning for donation during the pandemic: COVID‐19 convalescent plasma versus standard blood product donors. Transfusion. 63(3). 552–563. 4 indexed citations
6.
Bagri, Anil, Rafael Ramiro de Assis, Cheng‐ting Tsai, et al.. (2022). Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment. Transfusion. 62(3). 570–583. 3 indexed citations
7.
Ward, Dawn C., et al.. (2021). Pathogen‐reduced platelets in pediatric and neonatal patients: Demographics, transfusion rates, and transfusion reactions. Transfusion. 61(10). 2869–2876. 5 indexed citations
8.
Ziman, Alyssa, et al.. (2021). How do we implement pathogen reduction technology, while maintaining an adequate platelet inventory for our patients?. Transfusion. 61(4). 1014–1022. 4 indexed citations
9.
Ward, Dawn C., et al.. (2021). Macroscopic and microscopic visual inspection of a formed clot in a cryoprecipitate unit. Transfusion. 61(9). 2526–2527. 1 indexed citations
10.
Ward, Dawn C., et al.. (2021). Who donates? Patterns of blood donation and donor characteristics at a university‐affiliated hospital‐based donor center. Transfusion. 62(2). 346–354. 1 indexed citations
11.
Liou, Sofia, et al.. (2021). False anemia due to total parenteral nutrition and lipid emulsion contamination. Transfusion. 62(1). 14–15. 1 indexed citations
12.
Klapper, Ellen, et al.. (2021). Too lean: Time to build back true resiliency in the national blood supply. Transfusion. 61(9). 2768–2771. 9 indexed citations
13.
Yazer, Mark H., Pouneh Beizai, Nicole L. Draper, et al.. (2016). The Crossmatch/Issue Ratio. American Journal of Clinical Pathology. 146(2). 238–243. 7 indexed citations
14.
Mazonson, Peter, et al.. (2016). Prevalence of Medical Conditions Potentially Amenable to Cellular Therapy among Families Privately Storing Umbilical Cord Blood. Maternal and Child Health Journal. 21(1). 208–214. 1 indexed citations
15.
Oikonomopoulos, Angelos, et al.. (2015). Optimization of human mesenchymal stem cell manufacturing: the effects of animal/xeno-free media. Scientific Reports. 5(1). 16570–16570. 136 indexed citations
16.
Vyas, Girish N., Cheryl A. Stoddart, M. Scott Killian, et al.. (2011). Derivation of non-infectious envelope proteins from virions isolated from plasma negative for HIV antibodies. Biologicals. 40(1). 15–20. 2 indexed citations
17.
Biswas, Hope H., Zhanna Kaidarova, George Garratty, et al.. (2010). Increased All-Cause and Cancer Mortality in HTLV-II Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(3). 290–296. 36 indexed citations
18.
Lü, Qun, et al.. (2008). Standardized protocol to identify high‐risk patients undergoing therapeutic apheresis procedures. Journal of Clinical Apheresis. 23(3). 111–115. 6 indexed citations
19.
20.
Figueroa, Priscilla, et al.. (2006). Nearly Two Decades Using the Check-Type to Prevent ABO-Incompatible Transfusions. American Journal of Clinical Pathology. 126(3). 422–426. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edwin Massey Breakdown of academic impact, for papers by José Orlando Bordin Breakdown of academic impact, for papers by G. Andreu Breakdown of academic impact, for papers by Markus B. Funk Breakdown of academic impact, for papers by Ellen Klapper Breakdown of academic impact, for papers by S. J. Urbaniak Breakdown of academic impact, for papers by Stella Larsson Breakdown of academic impact, for papers by J. W. Andersen Breakdown of academic impact, for papers by Michael Müller‐Steinhardt Breakdown of academic impact, for papers by Byron A. Myhre
Rankless by CCL
2026